Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage.

AUTOR(ES)

Mårtensson, J

RESUMO

Treatment of newborn rats and mice with buthionine sulfoximine, an inhibitor of glutathione synthesis, leads to development of cataracts, which are not prevented by treatment with glutathione, but they are prevented by treatment with glutathione monoester. Cataracts are associated with glutathione deficiency in the lens epithelium, which undergoes severe degeneration. The findings indicate that glutathione normally functions in the protection of the lens and lens epithelium against oxidative injury, suggesting that procedures that increase lens glutathione levels might be useful for prevention of other types of cataracts. Relatively low doses of buthionine sulfoximine produce cataracts in newborn animals, and treatment of pregnant mice with buthionine sulfoximine during the last part of gestation leads to cataract formation in the offspring. The high sensitivity of the developing lens to the effects of glutathione deficiency suggests that this tissue may be a useful model for studies on glutathione function.

Documentos Relacionados

• The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO)
• Antioxidant Response to NaCl Stress in a Control and an NaCl-Tolerant Cotton Cell Line Grown in the Presence of Paraquat, Buthionine Sulfoximine, and Exogenous Glutathione.
• Avidin is induced in chicken embryo fibroblasts by viral transformation and cell damage.
• Buthionine Sulfoximine Increases the Toxicity of Nifurtimox and Benznidazole to Trypanosoma cruzi
• Alveolar epithelial damage. A critical difference between high pressure and oleic acid-induced low pressure pulmonary edema.